Fig. 1From: The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?ECM components in normal tissue and in the TME. During stiffening, the ECM is remodelled by the ECM components secreted both by cancer and stromal cells. This, in turn, affects the tissue mechanosignalling and its permeability for different therapeutic agentsBack to article page